In women, the SIRs were significantly high among breast cancer survivors for ovarian cancer and colorectal cancer survivors for uterus cancers, possibly due to hereditary breast and ovarian cancer and Lynch syndrome harboring a germline mutation in BRCA1/2 and mismatch repair–related genes, respectively. Here, BRCA1 is linked to uterine cancer.